Lerdelimumab: 6B1, Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, Anti-Transforming-Growth-Factor-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, CAT 152, Human Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology

Author:  

Publisher: Adis International

ISSN: 1174-5886

Source: Drugs in R&D, Vol.3, Iss.2, 2002-02, pp. : 106-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract